- Policy & Regulation
- Regulatory Trackers
- European Performance Tracker
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Arrayit Corporation
Manufacturers face risk of whistle-blower suits and government enforcement actions when emergency use authorizations expire and pandemic recedes, attorneys say, but interaction with FDA and documentation may mitigate risk.